Last reviewed · How we verify

Placebo oil for oral use

McMaster University · Phase 3 active Small molecule

Placebo oil for oral use is a Small molecule drug developed by McMaster University. It is currently in Phase 3 development for Oral use.

This drug is a placebo oil that has no active pharmacological effect.

This drug is a placebo oil that has no active pharmacological effect. Used for Oral use.

At a glance

Generic namePlacebo oil for oral use
SponsorMcMaster University
ModalitySmall molecule
PhasePhase 3

Mechanism of action

As a placebo oil, it is designed to mimic the appearance and feel of a real medication, but without any actual therapeutic effect. This allows researchers to compare the effects of the real medication to a control group, helping to establish its efficacy and safety.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo oil for oral use

What is Placebo oil for oral use?

Placebo oil for oral use is a Small molecule drug developed by McMaster University, indicated for Oral use.

How does Placebo oil for oral use work?

This drug is a placebo oil that has no active pharmacological effect.

What is Placebo oil for oral use used for?

Placebo oil for oral use is indicated for Oral use.

Who makes Placebo oil for oral use?

Placebo oil for oral use is developed by McMaster University (see full McMaster University pipeline at /company/mcmaster-university).

What development phase is Placebo oil for oral use in?

Placebo oil for oral use is in Phase 3.

Related